Skip to main content

Dr. Harmatz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Harmatz's full profile

Already have an account?

  • Office

    747 52nd St
    Oakland, CA 94609
    Phone+1 510-428-3058
    Fax+1 510-450-5813

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Gastroenterology, 1979 - 1982
  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 1976 - 1979
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1976

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2024 - 2027
  • MT State Medical License
    MT State Medical License 2022 - 2026
  • NM State Medical License
    NM State Medical License 2023 - 2026
  • OH State Medical License
    OH State Medical License 2022 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • CA State Medical License
    CA State Medical License 1977 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Gastroenterology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Rare, Deadly Genetic Disease Successfully Treated in Utero for First Time
    Rare, Deadly Genetic Disease Successfully Treated in Utero for First TimeNovember 9th, 2022
  • BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting Demonstrating Commitment to Understanding Achondroplasia and Potential Treatment Choice
    BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting Demonstrating Commitment to Understanding Achondroplasia and Potential Treatment ChoiceApril 15th, 2021
  • JCR Pharmaceuticals Announces Approval of IZCARGO® (Pabinafusp Alfa) for Treatment of MPS II (Hunter Syndrome) in Japan
    JCR Pharmaceuticals Announces Approval of IZCARGO® (Pabinafusp Alfa) for Treatment of MPS II (Hunter Syndrome) in JapanMarch 23rd, 2021
  • Join now to see all